BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36513815)

  • 1. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study.
    Jansen-Winkeln B; Eberth J; Moulla Y; Mehdorn M; Niebisch S; Schierle K; Bläker H; Lordick F; Gockel I; Thieme R
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1331-1341. PubMed ID: 36513815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
    Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer.
    Gockel I; Jansen-Winkeln B; Haase L; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    Tumori; 2020 Feb; 106(1):70-78. PubMed ID: 31469058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
    World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Clinical Safety and Feasibility Data of Whole-body Hyperthermia Pressurized Intraperitoneal Aerosol Chemotherapy (WBH-PIPAC) for Peritoneal Surface Malignancies.
    Kockelmann F; Giger-Pabst U; Ouaissi M; Bucur P; Barbey S; VON Ardenne A; Zieren J
    Anticancer Res; 2024 Jul; 44(7):3043-3050. PubMed ID: 38925817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.
    Eftimie MA; Potlog G; Alexandrescu ST
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].
    Jansen-Winkeln B; Thieme R; Haase L; Niebisch S; Pommer C; Lyros O; Zimmer J; Lordick F; Remane Y; Frontini R; Gockel I
    Chirurg; 2019 Feb; 90(2):137-145. PubMed ID: 29947920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM).
    Somashekhar SP; Rohit KC; Deo SVS; Ashwin KR
    Pleura Peritoneum; 2020 Sep; 5(3):20200120. PubMed ID: 33364340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Feasibility of High-Pressure/High-Dose Pressurized Intraperitoneal Aerosol Chemotherapy (HP/HD-PIPAC) for Primary and Metastatic Peritoneal Surface Malignancies.
    Ramos Arias G; Sindayigaya R; Ouaissi M; Buggisch JR; Schmeding M; Giger-Pabst U; Zieren J
    Ann Surg Oncol; 2023 Apr; 30(4):2497-2505. PubMed ID: 36400887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
    Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study.
    Gockel I; Jansen-Winkeln B; Haase L; Rhode P; Mehdorn M; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    J Gastric Cancer; 2018 Dec; 18(4):379-391. PubMed ID: 30607301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
    Eveno C; Jouvin I; Pocard M
    Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
    Tidadini F; Abba J; Quesada JL; Trilling B; Bonne A; Foote A; Faucheron JL; Arvieux C
    J Gastrointest Cancer; 2023 Jun; 54(2):632-641. PubMed ID: 35778645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
    Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC).
    Teixeira Farinha H; Mattille D; Mantziari S; Demartines N; Hübner M
    BMC Surg; 2022 Mar; 22(1):122. PubMed ID: 35354404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
    Kepenekian V; Péron J; You B; Bonnefoy I; Villeneuve L; Alyami M; Bakrin N; Rousset P; Benzerdjeb N; Glehen O
    Ann Surg Oncol; 2022 Mar; 29(3):2104-2113. PubMed ID: 34713369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.